Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Aggressive B-cell and T-cell Non-Hodgkin Lymphomas, Primary Mediastinal B-Cell Lymphoma, and Burkitt Lymphoma.
Approved for use in oncology care according to FDA-approved indications.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
Advanced or metastatic solid tumors or hematologic malignancies expressing targeted surface antigens.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Prevention and management of chemotherapy-related organ toxicities and complications.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Targeted treatment of solid tumors and hematologic malignancies.
Testicular, Ovarian, Bladder, Lung, Colorectal, Gastric, and Head & Neck Cancers.
Targeted treatment of solid tumors and hematologic malignancies.
Targeted treatment of solid tumors and hematologic malignancies.